Richard J Kuhn

Title: Richard J Kuhn: Innovator in Vaccine Development

Introduction

Richard J Kuhn is a prominent inventor based in West Lafayette, IN (US). He has made significant contributions to the field of virology, particularly in the development of vaccine compositions and retroviral technologies. With a total of 2 patents, his work has had a substantial impact on the understanding and treatment of diseases caused by flaviviruses.

Latest Patents

Kuhn's latest patents include innovative approaches to vaccine compositions and the production of pseudotyped retroviruses. The first patent focuses on nonstructural protein 1 (NS1) from flaviviruses, detailing its diagnostic and therapeutic uses to treat and prevent diseases caused by these viruses. The second patent describes methods for producing cells that generate pseudotyped retroviruses with a broad host range. This invention includes techniques for screening agents that block viral entry into cells and methods for introducing nucleotide sequences into target cells.

Career Highlights

Throughout his career, Richard J Kuhn has been associated with esteemed institutions such as the Purdue Research Foundation and the University of Michigan. His work has been instrumental in advancing the field of virology and vaccine development.

Collaborations

Kuhn has collaborated with notable colleagues, including Cynthia L North and Michael A Fishbach. These partnerships have contributed to the success of his research and innovations.

Conclusion

Richard J Kuhn's contributions to vaccine development and retroviral research highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to influence advancements in virology and public health.